|
|
|
|
|
|
|
|
|
|
medical news
....For the majority of patients in the study, olaparib was at least their third different cancer therapy. Based on the new data, the authors say olaparib warrants further investigation in phase III trials.....
Wednesday, November 12, 2014
Promising treatment option (Olaparib) and improved survival rates for patients with ovarian, breast, pancreatic, and prostate cancers - Medical News Today
medical news
....For the majority of patients in the study, olaparib was at least their third different cancer therapy. Based on the new data, the authors say olaparib warrants further investigation in phase III trials.....
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.